论文信息 - Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza - 字舞流文

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Lei S. Qi | D. Endy | N. Heaton | D. Lewis | R. Debs | Xueqiu Lin | Yanxia Liu | Marie La Russa | Timothy R. Abbott | Nicholas S. Heaton | Augustine Chemparathy | Stephen A. Chmura | Girija R. Dhamdhere | Leiping Zeng | Laine Goudy | Tara Pande | A. Chemparathy | D. Lewis